Safety and Efficacy of Electrospun Polycarbonate-Urethane Vascular Graft for Early Hemodialysis Access: First Clinical Results in Man

2011 ◽  
Vol 12 (1) ◽  
pp. 28-35 ◽  
Author(s):  
Serosha M. Wijeyaratne ◽  
Lushanthi Kannangara
Keyword(s):  
Vascular Graft ◽  
Clinical Results ◽  
Hemodialysis Access ◽  
Safety And Efficacy ◽  
Polycarbonate Urethane

Early Experience with a Newly Developed Electrospun Polycarbonate-urethane Vascular Graft for Hemodialysis Access

2013 ◽  
Vol 14 (3) ◽  
pp. 252-256 ◽  
Author(s):  
Mariano Ferraresso ◽  
Silvio Bertoli ◽  
Paolo Nobili ◽  
Ettore Maria Bortolani
Keyword(s):  
Vascular Graft ◽  
Early Experience ◽  
Hemodialysis Access ◽  
Polycarbonate Urethane

Design and Evaluation of a Structural Reinforced Small Intestinal Submucosa Vascular Graft for Hemodialysis Access in a Porcine Model

ASAIO Journal ◽  
2018 ◽  
Vol 64 (2) ◽  
pp. 270-277 ◽  
Author(s):  
Juliana Jaramillo ◽  
Karen T. Valencia-Rivero ◽  
Francisco J. Cedano-Serrano ◽  
Rocío López ◽  
Néstor Sandoval ◽  
...  
Keyword(s):  
Vascular Graft ◽  
Porcine Model ◽  
Small Intestinal Submucosa ◽  
Hemodialysis Access ◽  
Small Intestinal ◽  
Intestinal Submucosa

scholarly journals NuSpun Vascular Graft: Using Nanotechnology That Mimics Nature for Hemodialysis Access

2019 ◽  
Vol 70 (3) ◽  
pp. e44-e45
Author(s):  
Yael Vin ◽  
Saif G. Pathan ◽  
Mauricio A. Contreras ◽  
Nathaniel F. Long ◽  
Rayan Kassab ◽  
...  
Keyword(s):  
Vascular Graft ◽  
Hemodialysis Access

Early experience with a novel self-sealing nanofabric vascular graft for early hemodialysis access

Vascular ◽  
2016 ◽  
Vol 24 (4) ◽  
pp. 421-424 ◽  
Author(s):  
Seyhan Yilmaz
Keyword(s):  
Vascular Graft ◽  
Early Experience ◽  
Central Venous Catheters ◽  
Primary Patency ◽  
Secondary Patency ◽  
Initial Experience ◽  
Hemodialysis Access ◽  
Central Venous ◽  
Access Graft ◽  
Graft Implantation

Aim To report initial experience regarding the use of novel self-sealing electrospun nanofabric graft. Material and methods A total of 21 patients aged between 22 and 64 (male:female ratio = 11:10) underwent AVflo vascular access graft implantation to forearm. Information for patency at 6 and 12 months after the operation was obtained. Cannulation for hemodialysis was allowed 8 h after the operation, as needed. Results Cannulation was performed before 12th hour of implantation in two patients, between 12th and 24th postoperative hours in 10 patients and between 12th and 24th postoperative hours in the remaining nine patients. Primary patency was 17/21 (80.9%) at 6th month and 15/21 (71.4%) at 12th month. Secondary patency was 19/21 (90.4%) at sixth month and 17/21 (80.9%) at 12th month. Conclusion AVflo self-sealing graft allows for early cannulation after implantation and thus may potentially eliminate the need for central venous catheters in selected patients.

Abstract WP155: The Safety And Efficacy Of Carotid Artery Stenting In A High Grade Stenosis More Than 80% Under Proximal Protection With Flow-reversal System.

Stroke ◽  
2013 ◽  
Vol 44 (suppl_1) ◽  
Author(s):  
Rie Yako ◽  
Osamu Masuo ◽  
Hiroyuki Matsumoto ◽  
Naoyuki Nakao ◽  
Tomoaki Terada ◽  
...  
Keyword(s):  
Carotid Artery ◽  
Carotid Artery Stenting ◽  
Reverse Flow ◽  
Clinical Results ◽  
High Grade ◽  
Protection Device ◽  
Safety And Efficacy ◽  
Significant Difference ◽  
Ischemic Complication ◽  
Distal Protection

Background: Different embolic protection devices in carotid artery stenting(CAS) have been developed to prevent procedural cerebral embolization. Proximal flow reverse protection has theoretically advantages from the view point of prevention of distal embolism, compared with distal protection. On the other hand, there is a disadvantage that this system is complexity. Purpose: we evaluated the safety and efficacy of proximal reverse flow protection for CAS in patients with high-grade stenosis. Methods: Distal protection has mainly been used as protection device in our institute. In case that there was high possibility of distal embolism, proximal reverse flow protection has been used. These cases treated with proximal flow reverse protection were included in this study. A total of 75 patients(71 men, mean age 71.9 years) with a high grade stenosis≧80% were treated between September 2003 and March 2012. 72% (n=54) of the patients were symptomatic.The primary endpoint was death and stroke rate at 30 days. The outcome was also compared to data from 386 patients with a high-grade stenosis who were treated under only distal protection device in the same period. Results: The procedure was technically successful in all cases. In 2 cases out of proximal reverse flow protection group, intracerebral hemorrhage was occurred. However, there was no ischemic complication. In distal protection group, the incidence of complication occurred in 11 cases (7 ischemic, 4 otheres). The stroke/death rate at 30 days was 2.6% (n=2) in proximal reverse flow protection group compared to 2.8% (n=11) in the distal protection group. There was no significant difference. However, the incidence of ischemic complication in the proximal reverse flow protection group tended to be lower than that of distal protection group. Conclusion: In selected patients with large atherosclerotic plaques, the clinical results of CAS with proximal reverse flow protection is safe and feasible. Especially, the incidence of ischemic stroke was lower than that of distal protection.

scholarly journals First human use of an allogeneic tissue-engineered vascular graft for hemodialysis access

2014 ◽  
Vol 60 (5) ◽  
pp. 1353-1357 ◽  
Author(s):  
Wojciech Wystrychowski ◽  
Todd N. McAllister ◽  
Krzysztof Zagalski ◽  
Nathalie Dusserre ◽  
Lech Cierpka ◽  
...  
Keyword(s):  
Vascular Graft ◽  
Hemodialysis Access ◽  
Human Use
Sign in / Sign up

Export Citation Format

Share Document